Emergent Stock Performance

EBS
 Stock
  

USD 28.43  0.96  3.27%   

The firm shows a Beta (market volatility) of 0.0391, which means not very significant fluctuations relative to the market. Let's try to break down what Emergent's beta means in this case. As returns on the market increase, Emergent Biosolutions returns are expected to increase less than the market. However, during the bear market, the loss on holding Emergent Biosolutions will be expected to be smaller as well. Even though it is essential to pay attention to Emergent Biosolutions historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards predicting any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Emergent Biosolutions exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Emergent Biosolutions has an expected return of -0.0843%. Please be advised to confirm Emergent Biosolutions value at risk, and the relationship between the jensen alpha and skewness to decide if Emergent Biosolutions performance from the past will be repeated at some point in the near future.
  
Emergent Performance
0 of 100
Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Emergent Biosolutions is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more

Emergent Price Channel

Quick Ratio2.48
Fifty Two Week Low26.85
Target High Price65.00
Fifty Two Week High65.09
Target Low Price30.00

Emergent Biosolutions Relative Risk vs. Return Landscape

If you would invest  3,169  in Emergent Biosolutions on May 19, 2022 and sell it today you would lose (326.00)  from holding Emergent Biosolutions or give up 10.29% of portfolio value over 90 days. Emergent Biosolutions is generating negative expected returns assuming volatility of 4.292% on return distribution over 90 days investment horizon. In other words, 37% of stocks are less volatile than Emergent, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the market. In addition to that, the company is 3.67 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.12 per unit of volatility.

Emergent Biosolutions Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Emergent Biosolutions' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Emergent Biosolutions, and traders can use it to determine the average amount a Emergent Biosolutions' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0196

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsEBS
Estimated Market Risk
 4.29
  actual daily
 
 37 %
of total potential
 
3737
Expected Return
 -0.08
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 -0.02
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Emergent Biosolutions is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Emergent Biosolutions by adding it to a well-diversified portfolio.

About Emergent Biosolutions Performance

To evaluate Emergent Biosolutions Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Emergent Biosolutions generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Emergent Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Emergent Biosolutions market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Emergent's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Effect of Exchange Rate Changes on Cash-300 K-307.9 K
Return on Investment 14.75  12.52 
Return on Average Assets 0.08  0.08 
Return on Average Equity 0.15  0.14 
Return on Invested Capital 0.17  0.16 
Return on Sales 0.20  0.21 
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats in the United States. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland. Emergent Biosolutions operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 2416 people.

Things to note about Emergent Biosolutions

Checking the ongoing alerts about Emergent Biosolutions for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Emergent Biosolutions help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Emergent Biosolutions Alerts

Equity Alerts and Improvement Suggestions

Emergent Biosolutions generated a negative expected return over the last 90 days
Emergent Biosolutions has high historical volatility and very poor performance
Emergent Biosolutions was previously known as EMERGENT BIOSOLUTIONS INC and was traded on New York Stock Exchange under the symbol EBS.
Emergent Biosolutions has a strong financial position based on the latest SEC filings
Over 88.0% of the company shares are held by institutions such as insurance companies
Latest headline from uk.yahoo.com: Emergent BioSolutions Inc.s Fundamentals Look Pretty Strong Could The Market Be Wrong About The Stock - Yahoo Movies UK
Continue to Investing Opportunities. Note that the Emergent Biosolutions information on this page should be used as a complementary analysis to other Emergent Biosolutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Emergent Stock analysis

When running Emergent Biosolutions price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Is Emergent Biosolutions' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emergent Biosolutions. If investors know Emergent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.022
Market Capitalization
1.5 B
Quarterly Revenue Growth YOY
-0.39
Return On Assets
0.049
Return On Equity
0.0631
The market value of Emergent Biosolutions is measured differently than its book value, which is the value of Emergent that is recorded on the company's balance sheet. Investors also form their own opinion of Emergent Biosolutions' value that differs from its market value or its book value, called intrinsic value, which is Emergent Biosolutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emergent Biosolutions' market value can be influenced by many factors that don't directly affect Emergent Biosolutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emergent Biosolutions' value and its price as these two are different measures arrived at by different means. Investors typically determine Emergent Biosolutions value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.